I'm a bit concerned as a shareholder not sure if its true...Is Cigna loosing its top Sales leadership talent due to under-performing product portfolio US Domestic Healthcare or is it a reflection of market re-configuration?
2 replies (most recent on top)
I'd agree with this 100%
In total, the enterprise is fine, yet, pockets of under-performance exist... Also, there are pockets where costs are out of control (e.g., IT, some groups in Corporate) - I'd expect more cuts there...
Sorry for typos, writing this on my phone
Nonetheless, the totality of the enterprise seems to be strong, wall street is happy and that's all that matters!
Very possibly a combination of both.
Under-performing US healthcare sales may be offset by a diversified multi-national portfolio, group life, etc. The value proposition of US healthcare sales could be watered down KoolAid.
Nonetheless, the totality of the enterprise seems to be strong, wall street is happy and that's all that matters!